Experimental Study of Key Stability Factors of Nanofluids Based on Transformer oil
Elektronnaya Obrabotka Materialov · 2026-05 · 62 (2) · 70-76
DOI: 10.52577/eom.2026.62.2.70 ↗Kurz gefasst
Fachartikel in der Zeitschrift Elektronnaya Obrabotka Materialov, 2026-05. Verfasst von Serghei Korobeinikov und 4 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this paper, the studies of the stability of nanofluids based on the transformer oil with the addition of titanium dioxide particles are described. Experimental procedures were established to determine the optimal ultrasonic dispersion power and surfactant concentrations. The sedimentation stability of the suspensions formulated with fresh versus service-aged transformer oil was compared. It was found that the nanoparticles exhibited an enhanced stability in the service-aged oil even in the absence of stabilizing agents. A theoretical explanation is proposed, attributing that phenomenon to the variation in the dispersion medium acidity and the displacement of the system relative to the nanoparticles isoelectric point.
Zitieren
APA
Korobeinikov, S., Vedernikov, D., Shevchenko, V., Ridel, A., & Kuskov, T. (2026). Experimental Study of Key Stability Factors of Nanofluids Based on Transformer oil. Elektronnaya Obrabotka Materialov, 62(2), 70-76. https://doi.org/10.52577/eom.2026.62.2.70
Vancouver
Korobeinikov S, Vedernikov D, Shevchenko V, Ridel A, Kuskov T. Experimental Study of Key Stability Factors of Nanofluids Based on Transformer oil. Elektronnaya Obrabotka Materialov. 2026;62(2):70-76. doi:10.52577/eom.2026.62.2.70
BibTeX
@article{Korobeinikov2026,
author = {Korobeinikov, Serghei and Vedernikov, D. and Shevchenko, V. and Ridel, A. and Kuskov, T.},
title = {Experimental Study of Key Stability Factors of Nanofluids Based on Transformer oil},
journal = {Elektronnaya Obrabotka Materialov},
year = {2026},
volume = {62},
number = {2},
pages = {70--76},
doi = {10.52577/eom.2026.62.2.70}
}
EUVIMED